Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Prudential Financial Inc.

Prudential Financial Inc. decreased its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 91.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 26,632 shares of the health services provider's stock after selling 273,976 shares during the period. Prudential Financial Inc.'s holdings in Teladoc Health were worth $242,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Geode Capital Management LLC raised its position in Teladoc Health by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock worth $36,042,000 after buying an additional 56,864 shares during the last quarter. Quantinno Capital Management LP increased its holdings in shares of Teladoc Health by 190.4% in the 3rd quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider's stock valued at $1,709,000 after purchasing an additional 122,050 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in shares of Teladoc Health by 21.8% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock valued at $6,365,000 after purchasing an additional 125,111 shares during the period. Versant Capital Management Inc boosted its holdings in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after buying an additional 2,441 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its position in Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock worth $3,874,000 after buying an additional 424,180 shares during the period. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Trading Down 1.8 %

Shares of TDOC traded down $0.13 during mid-day trading on Wednesday, hitting $7.02. The company had a trading volume of 409,380 shares, compared to its average volume of 6,215,035. Teladoc Health, Inc. has a 1-year low of $6.61 and a 1-year high of $15.21. The business's 50-day simple moving average is $9.56 and its 200-day simple moving average is $9.68. The stock has a market cap of $1.23 billion, a PE ratio of -1.21 and a beta of 1.73. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Sell-side analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Transactions at Teladoc Health

In related news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now owns 64,308 shares in the company, valued at approximately $541,473.36. The trade was a 14.62 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.95% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on TDOC shares. Oppenheimer lowered their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating on the stock in a report on Friday, January 24th. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research report on Thursday, February 27th. Bank of America dropped their target price on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating for the company in a report on Friday, April 11th. The Goldman Sachs Group dropped their price objective on shares of Teladoc Health from $16.00 to $13.00 and set a "buy" rating for the company in a research note on Monday, March 3rd. Finally, Piper Sandler lowered their target price on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Teladoc Health currently has an average rating of "Hold" and an average target price of $10.94.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.